Selected article for: "future study and International license"
Author: Svenja Weiss; Jeromine Klingler; Catarina Hioe; Fatima Amanat; Ian Baine; Erna Milunka Kojic; Jonathan Stoever; Sean Liu; Denise Jurczyszak; Maria Bermudez-Gonzalez; Viviana Simon; Florian Krammer; Susan Zolla-Pazner
Title: A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2
  • Document date: 2020_4_17
    • ID: 9iwjtwyx_9
    Snippet: Human samples. Banked serum samples were obtained from study participants enrolled in two IRB- to the spread of SARS-Cov-2 in the USA, served as negative controls (N#1, N#2, N#3). All participants provided written consent at study enrollment and agreed to sample banking and future research use of . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetu.....
    Document: Human samples. Banked serum samples were obtained from study participants enrolled in two IRB- to the spread of SARS-Cov-2 in the USA, served as negative controls (N#1, N#2, N#3). All participants provided written consent at study enrollment and agreed to sample banking and future research use of . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and human sample: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and negative control: 1, 2, 3, 4, 5, 6, 7, 8
    • cc NC ND International license and SARS USA spread: 1
    • cc NC ND International license and study participant: 1, 2
    • human sample and International license: 1, 2
    • human sample and negative control: 1
    • human sample and serum sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • human sample and study enrollment: 1
    • International license and negative control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • International license and SARS USA spread: 1
    • International license and serum sample: 1
    • International license and study participant: 1, 2
    • negative control and serum sample: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • serum sample and study enrollment: 1
    • serum sample and study participant: 1